Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 3/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 6/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | RAF1 | P04049 | 2/20 | 0.31 |
| ▸ | BRAF | P15056 | 2/20 | 0.31 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21998970 | 0.93 | PTPN1 (0.32) | SCN9APTPN1 | |
| SCHEMBL18498639 | 0.91 | DDR1 (0.39) | SCN9APTPN1IRAK4DDR1 | |
| SCHEMBL21999360 | 0.90 | DDR1 (0.37) | SCN9AIRAK4ALDH1A1DDR1 | |
| SCHEMBL21999189 | 0.88 | F10 (0.36) | SCN9AIRAK4 | |
| SCHEMBL21999358 | 0.85 | PIK3CD (0.32) | PDE2APIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL21999758 | 0.84 | PDE2A (0.30) | PDE2A | |
| SCHEMBL21998965 | 0.83 | DDR1 (0.35) | SCN9APTPN1DDR1 | |
| SCHEMBL21999188 | 0.83 | DDR1 (0.33) | PDE2ADDR1 | |
| SCHEMBL21999183 | 0.81 | MAPK14 (0.34) | SCN9A | |
| SCHEMBL21999760 | 0.80 | PIK3CG (0.31) | PDE2APTGS2PIK3CDPIK3CAPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11089783-B2 | 2-(het)aryl-substituted fused heterocycle derivatives as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2021-08-17 | — | — | US | disclosed |
| US-20200146293-A1 | 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11089783-B2 | 2-(het)aryl-substituted fused heterocycle derivatives as pesticides | AHR, DDT, CYP8B1 | SCN9A 2083/4885PTPN1 1739/4885IRAK4 3604/4885 |
| US-20200146293-A1 | 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES | AHR, DDT, CYP8B1 | SCN9A 2083/4885PTPN1 1739/4885IRAK4 3604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.